Monday, September 17, 2018

IHH Healthcare Berhad (MYX: 5225)

https://en.wikipedia.org/wiki/IHH_Healthcare

IHH Healthcare Berhad
Publicly traded government-linked company
Traded asMYX5225
ISINMYL5225OO007
IndustryHealthcare
PredecessorIntegrated Healthcare Holdings Bhd
Founded1974
HeadquartersKuala LumpurMalaysia
Areas served
Asia, Central and Eastern Europe, the Middle East and North Africa
Key people
Dato' Mohammed Azlan bin Hashim, Chairman
Tan See Leng, Group Managing Director & CEO
Number of employees
35,000
ParentKhazanah Nasional
SubsidiariesParkway PantaiAcıbadem Healthcare GroupInternational Medical University
Websiteihh-healthcare.com
IHH Healthcare Berhad (MYX5225) is a MalaysianSingaporean private healthcare group focused on upmarket health services, and Asia's largest private healthcare group.

  It is headquartered in Kuala Lumpur and has activities in the private hospital and health sector throughout Asia, Central and Eastern Europe, North Africa and the Middle East, notably in SingaporeBruneiChinaHong KongMalaysiaTurkey and the United Arab Emirates.

 The group has over 35,000 employees. It is listed on Bursa Malaysia and the Singapore Exchange.[1] In recent years IHH has expanded significantly in India, China and the Middle East.
IHH owns Singapore-based Parkway Pantai, the largest private hospital operator of Southeast Asia, and the International Medical University in Kuala Lumpur, and is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company. IHH owns 52.3%[2] of the Hyderabad-based private healthcare provider Continental Hospitals Limited in India.
The majority shareholder of IHH Healthcare is the Malaysian government's sovereign wealth fund Khazanah Nasional, followed by Mitsui of Japan and Citigroup of the United States.

http://www.ihhhealthcare.com/

IHH Healthcare Berhad ("IHH or the Group") is a leading international provider of premium integrated healthcare services operating in the home markets of Malaysia, Singapore, Turkey and India. The Group also has a growing presence in Greater China and an expanding network across Asia and Central and Eastern Europe, the Middle East and North Africa("CEEMENA"). We are one of the largest healthcare groups in the world by market capitalisation and are listed on the Main Markets of Bursa Malaysia and the Singapore Stock Exchange.
The Group comprises premium-brand healthcare assets, collectively representing a unique multi-market investment position in the healthcare sector. Our "Mount Elizabeth", "Gleneagles", "Pantai", "Parkway" and "Acibadem" brands are among the most prestigious in Asia and Central and Eastern Europe.

IHH's pathway has been clear from the outset - operating in markets where the demand for quality healthcare is growing rapidly especially where there are increasingly affluent and rapidly ageing populations. We continue to respond to the opportunities presented by the burgeoning medical travel sector, investing in facilities distinguished by their ability to meet the changing needs and demographics of the communities they serve.


OVERVIEW
No. of
hospitals
Singapore
4
Malaysia
14




India
9
Turkey*
 
21
No. of
operational beds
Singapore
928
Malaysia
2,182
India
1,192
Turkey*
 
3,818
No. Of Inpatient
admissions
 
Singapore
76,459
Malaysia
197,563
India
72,005
Turkey*
 
213,590
Average
revenue
per inpatient admission (MYR)
Singapore
29,127
Malaysia
6,237
India
7,780
Turkey*
 
8,264


No comments: